+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Contrast Media Injectors Market to 2025 - Regional Analysis and Forecasts by Product; Application; and Country

  • PDF Icon

    Report

  • 130 Pages
  • April 2019
  • Region: North America
  • The Insight Partners
  • ID: 4769889
UP TO OFF until Mar 31st 2024
The North America contrast media injectors market is expected to reach US$ 507.8 Mn in 2027 from US$ 271.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.3% from 2019-2027.

The growth of the contrast media injectors market is primarily attributed to the increasing number of approvals for contrast agents and increasing number of patients suffering with chronic diseases. However, side effects associated with the contrast media agents and shortage of skilled professionals. On the other hand, robust pipeline products and emergence of local players are likely to have a positive impact on the growth of the North America contrast media injectors market in the coming years.

Contrast materials also known as contrast media or contrast agents are used to enhance the quality of images of the inside body generally produced by the use of x-rays, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. These agents are helpful in diagnosis and treatment monitoring as they often allow radiologists to distinguish normal from abnormal conditions. The contrast media agents are critical components as they may pose threats to patients as they are injected in the body. Thus, the proper composition of these media agents are of prime importance for successful and harmless imaging. In the recent years, with the increasing use of contrast media for medical imaging, the manufacturers are investing significant efforts to develop micro-bubble contrast materials that are harmless to human body and helps to express the targets. For instance, in April 2016, the US Food and Drug Administration approved LUMASON, also known as SonoVue, manufactured by Bracco Diagnostics intended for use in liver imaging for the characterization of focal liver lesions in adult and pediatric patients. Furthermore, in May 2018, General Electric received FDA indication approval for Visipaque (iodixanol) injection for use with coronary CT angiography. Thus, such the launch of new contrast media agents in the country are likely to be responsible for the growth of the US contrast media injectors market.

In 2018, the consumables segment held a largest market share of 62.8% of the contrast media injectors market, by product. This segment is also expected to dominate the market in 2027 owing to rising adoption of contrast media injectors. Moreover, the similar segment is anticipated to witness the significant growth rate of 7.7% during the forecast period.

North America contrast media injectors market, based on application was segmented into interventional cardiology, interventional radiology and radiology. The radiology segment is the largest segment which anticipated to grow at a CAGR of 6.3% during the forecast period. Moreover, the interventional cardiology segment is expected to grow at the fastest rate during the coming years owing to introduction of innovative products in the field of interventional cardiology.

Some of the major primary and secondary sources for contrast media injectors included in the report are, America Board of Radiology (ABR), American Heart Association (AHA), Centers for Disease Control & Prevention (CDC), Medicare Access and CHIP Reauthorization Act (MACRA), Food and Drug Administration (FDA), World Health Organization (WHO) and others.

Table of Contents

PART 1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 REPORT GUIDANCE
PART 2. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET - KEY TAKEAWAYS
PART 3. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 North America Contrast Media Injectors Market - By Product
3.2.2 North America Contrast Media Injectors Market - By Application
3.2.3 North America Contrast Media Injectors Market - By Country
3.3 PEST ANALYSIS
PART 4. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET-KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Number of Approvals for Contrast Agents
4.1.2 Increasing Number of Patients Suffering with Chronic Diseases
4.2 KEY MARKET RESTRAINTS
4.2.1 Side Effects Associated with the Contrast Media Agents
4.2.2 Shortage of Skilled Professionals
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Robust Pipeline Products
4.3.2 Emergence of Local Players
4.4 FUTURE TRENDS
4.4.1 Increasing Adoption of Syringe-less Power Injectors
4.5 IMPACT ANALYSIS
PART 5. CONTRAST MEDIA INJECTORS MARKET - NORTH AMERICA ANALYSIS
5.1 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING
5.3 EXPERT OPINIONS
PART 6. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET ANALYSIS - BY PRODUCT
6.1 OVERVIEW
6.2 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET BY PRODUCT, 2018 & 2027 (%)
6.3 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
6.4 INJECTOR SYSTEMS MARKET
6.4.1 Overview
6.4.2 North America Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.3 MRI Injector Systems Market
6.4.3.1 Overview
6.4.3.2 North America MRI Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.4 CT Injector Systems Market
6.4.4.1 Overview
6.4.4.2 North America CT Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.5 Angiography Injector Systems Market
6.4.5.1 Overview
6.4.5.2 North America Angiography Injector Systems Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 CONSUMABLES MARKET
6.5.1 Overview
6.5.2 North America Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3 Injector Heads Market
6.5.3.1 Overview
6.5.3.2 North America Injector Heads Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3.3 Single Head Injectors Market
6.5.3.3.1 Overview
6.5.3.3.2 North America Single Head Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3.4 Dual Head Injectors Market
6.5.3.4.1 Overview
6.5.3.4.2 North America Dual Head Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3.5 Syringeless Injectors Market
6.5.3.5.1 Overview
6.5.3.5.2 North America Syringeless Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.4 Tubing Market
6.5.4.1 Overview
6.5.4.2 North America Tubing Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.5 Syringes Market
6.5.5.1 Overview
6.5.5.2 North America Syringes Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.6 Other Consumables Market
6.5.6.1 Overview
6.5.6.2 North America Other Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
6.6 ACCESSORIES MARKET
6.6.1 Overview
6.6.2 North America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
PART 7. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET ANALYSIS - BY APPLICATION
7.1 OVERVIEW
7.2 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2018 & 2027 (%)
7.3 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
7.4 INTERVENTIONAL CARDIOLOGY MARKET
7.4.1 Overview
7.4.2 North America Interventional Cardiology Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 INTERVENTIONAL RADIOLOGY MARKET
7.5.1 Overview
7.5.2 North America Interventional Radiology Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 RADIOLOGY MARKET
7.6.1 Overview
7.6.2 US Radiology Market Revenue and Forecasts to 2027 (US$ Mn)
PART 8. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027
8.1 OVERVIEW
8.2 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
8.3.1 North America Injector Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 North America Consumables Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2.1 US Injector Heads Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
8.5 NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
8.6 US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.1 US Contrast Media Injectors market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 US Contrast Media Injectors Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.2.1 US Injector Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2 US Consumables Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2.1 US Injector Heads Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.3 US Contrast Media Injectors Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.7 CANADA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.1 Canada Contrast Media Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Canada Contrast Media Injectors Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Canada Injector Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Canada Consumables Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2.1 Canada Injector Heads Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Canada Contrast Media Injectors Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.8 MEXICO CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.1 Mexico Contrast Media Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 Mexico Contrast Media Injectors Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 Mexico Injector Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 Mexico Consumables Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2.1 Mexico Injector Heads Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 Mexico Contrast Media Injectors Market Revenue And Forecasts to 2027, By Application (US$ Mn)
PART 9. CONTRAST MEDIA INJECTORS MARKET-KEY COMPANY PROFILES
9.1 BAYER AG
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Financial Overview
9.1.4 Product Portfolio
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 NEMOTO KYORINDO CO., LTD.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Financial Overview
9.2.4 Product Portfolio
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 SHENZHEN XINGUAN ELECTROMECHANICAL CO. LTD.
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Financial Overview
9.3.4 Product Portfolio
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 GENERAL ELECTRIC
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Financial Overview
9.4.4 Product Portfolio
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 ANGIODYNAMICS
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Financial Overview
9.5.4 Product Portfolio
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 ULRICH GMBH & CO.KG
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Financial Overview
9.6.4 Product Portfolio
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 APOLLO RT CO. LTD.
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Financial Overview
9.7.4 Product Portfolio
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 BRACCO IMAGING S.P.A.
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Financial Overview
9.8.4 Product Portfolio
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 GUERBET GROUP
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Financial Overview
9.9.4 Product Portfolio
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 COOK MEDICAL INCORPORATED
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Financial Overview
9.10.4 Product portfolio
9.10.5 SWOT ANALYSIS
9.10.6 KEY DEVELOPMENTS
9.11 SMITHS MEDICAL
9.11.1 Key Facts
9.11.2 Business Description
9.11.3 Financial Overview
9.11.4 Product Portfolio
9.11.5 SWOT Analysis
9.11.6 Key Developments
9.12 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.
9.12.1 Key Facts
9.12.2 Business Description
9.12.3 Financial Overview
9.12.4 Product Portfolio
9.12.5 SWOT Analysis
9.12.6 Key Developments
9.13 BOSTON SCIENTIFIC CORPORATION
9.13.1 Key Facts
9.13.2 Business Description
9.13.3 Financial Overview
9.13.4 Product Portfolio
9.13.5 SWOT Analysis
9.13.6 Key Developments
PART 10. APPENDIX
10.1 ABOUT THE PUBLISHER
10.2 GLOSSARY OF TERMS
10.3 METHODOLOGY
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
LIST OF TABLES
TABLE 1. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 3. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 4. NORTH AMERICA INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. NORTH AMERICA CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 6. US INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 7. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 8. US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 9. US INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 10. US CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 11. US INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 12. US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 13. CANADA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 14. CANADA INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 15. CANADA CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 16. CANADA INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 17. CANADA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 18. MEXICO CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 19. MEXICO INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 20. MEXICO CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 21. MEXICO INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 22. MEXICO CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 23. GLOSSARY OF TERMS, CONTRAST MEDIA INJECTORS MARKET
LIST OF FIGURES
FIGURE 1. US CONTRAST MEDIA INJECTORS MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2027
FIGURE 2. US CONTRAST MEDIA INJECTORS MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 3. US CONTRAST MEDIA INJECTORS MARKET BY TYPE, MARKET SHARE (%), 2018
FIGURE 4. CONTRAST MEDIA INJECTORS MARKET SEGMENTATION
FIGURE 5. NORTH AMERICA PEST ANALYSIS
FIGURE 6. CONTRAST MEDIA INJECTORS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 7. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET - REVENUE FORECASTS AND ANALYSIS - 2018- 2027
FIGURE 8. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 2018 & 2027 (%)
FIGURE 9. NORTH AMERICA INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 10. NORTH AMERICA MRI INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 11. NORTH AMERICA CT INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 12. NORTH AMERICA ANGIOGRAPHY INJECTOR SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 13. NORTH AMERICA CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 14. NORTH AMERICA INJECTOR HEADS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 15. NORTH AMERICA SINGLE HEAD INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. NORTH AMERICA DUAL HEAD INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. NORTH AMERICA SYRINGELESS INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. NORTH AMERICA TUBING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. NORTH AMERICA SYRINGES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. NORTH AMERICA OTHER CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. NORTH AMERICA ACCESSORIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET BY APPLICATION, 2018 & 2027 (%)
FIGURE 23. NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 24. NORTH AMERICA INTERVENTIONAL RADIOLOGY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. US RADIOLOGY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE OVERVIEW, BY COUNTRY, 2018 (US$ MN)
FIGURE 27. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 28. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 29. US CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. CANADA CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 31. MEXICO CONTRAST MEDIA INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corporation

  • Shenzhen Xinguan Electromechanical Co. Ltd.

  • ulrich GmbH & Co.KG.

  • APOLLO RT Co. Ltd.

  • Bracco Imaging S.p.A.

  • Guerbet SA

  • Cook Medical Incorporated

  • Smiths Medical

  • Sino Medical-Device Technology Co., Ltd.,

  • Bayer AG

  • Nemoto Kyorindo Co., Ltd.

  • General Electric

  • AngioDynamics